Sign in: Staff/Students
University of Liverpool researchers have secured funding to develop an online tool that will help the future development of personalised medicines.
Personalised, or stratified medicine as it is also known, is a growing area of research which aims to tailor the treatment given to a patient according to one or more personal characteristics. These characteristics can be demographic such as age or gender, or biological such as a genetic or other biomarker.
A number of clinical trial designs have been proposed for testing a biomarker’s usefulness, including clinical trials which aim to test the effectiveness of a biomarker-guided approach to treatment.
PhD student Miranta Antoniou, supervised by Dr Ruwanthi Kolamunnage-Dona and Dr Andrea Jorgensen at the University, has conducted a comprehensive review of biomarker-guided adaptive trial designs proposed in the past decade, and has developed an in-depth overview for researchers in this field.
As a result of the review, the Medical Research Council’s Network of Hubs for Trials Methodology Research’s Stratified Medicine Working Group (MRC HTMR SMWG), co-led by Dr Jorgensen from the University’s Institute of Translational Medicine and Dr James Wason from the University of Cambridge, has secured funding from the MRC to develop an online tool for guidance on designing biomarker-guided randomised controlled trials (RCTs).
Dr Jorgensen, said: “The information gained from the review will provide the foundation for the development of a user-friendly online tool to assist those embarking on biomarker trials.
“Our aim is to develop a tool that will result in greater efficiency of trials and ultimately boost the development of personalised treatments in the future.”
The research paper entitled ‘Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review’ can be found here.
You must be logged in to post a comment.
All recent news
Event: How can we change our fashion consumption to become more sustainable?
Student stories: Industry placement experiences
First patient dosed in latest stage of AGILE COVID-19 drug trial
Episode 5: Chris Witterick
Episode 4: Hannah Forbes
Our paper on immune responses to COVID vaccine (mostly Pfizer) in 237 healthcare workers, 124 #SARSCoV2 naïve and 113 previously infected, from the PITCH consortium @pitchstudy is out as a pre-print today.
See if you can spot us in the new @NetflixUK series, The Irregulars! 📽️
Our @VictoriaGallery appears in it, as well as other locations across the city including St George’s Plateau, the Palm House in Sefton Park and Falkner Street in the Georgian Quarter.
Professor Michael Parkinson CBE, author of 1985's Liverpool on the Brink, and Liverpool Beyond the Brink in 2019, analyses the Caller Report, the Gov's Best Value inspection into Liverpool City Council